Mycobacterium bovis BCG infection alters the macrophage N-glycome.
BCG Vaccine
/ administration & dosage
Cells, Cultured
Cytokines
/ metabolism
Epitopes
/ metabolism
Glycomics
/ methods
Host-Pathogen Interactions
/ immunology
Humans
Inflammation Mediators
/ metabolism
Macrophages
/ immunology
Mycobacterium bovis
/ immunology
Mycobacterium tuberculosis
/ immunology
Polysaccharides
/ chemistry
THP-1 Cells
Tuberculosis
/ immunology
Journal
Molecular omics
ISSN: 2515-4184
Titre abrégé: Mol Omics
Pays: England
ID NLM: 101713384
Informations de publication
Date de publication:
01 08 2020
01 08 2020
Historique:
pubmed:
10
4
2020
medline:
2
6
2021
entrez:
10
4
2020
Statut:
ppublish
Résumé
Macrophage glycosylation is essential to initiate the host-immune defense but may also be targeted by pathogens to promote infection. Indeed, the alteration of the cell-surface glycosylation status may affect the binding of lectins involved in cell activation and adhesion. Herein, we demonstrate that infection by M. bovis BCG induces the remodeling of the N-glycomes of both human primary blood monocyte-derived macrophages (MDM) and macrophage-cell line THP1. MALDI-MS based N-glycomic analysis established that mycobacterial infection induced increased synthesis of biantennary and multifucosylated complex type N-glycans. In contrast, infection of macrophages by M. bovis BCG did not modify the glycosphingolipids composition of macrophages. Further nano-LC-MS
Substances chimiques
BCG Vaccine
0
Cytokines
0
Epitopes
0
Inflammation Mediators
0
Polysaccharides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM